Local and systemic delivery of VEGF siRNA using polyelectrolyte complex micelles for effective treatment of cancer

被引:300
作者
Kim, Sun Hwa [1 ]
Jeong, Ji Hoon [2 ]
Lee, Soo Hyeon [1 ]
Kim, Sung Wan [3 ,4 ]
Park, Tae Gwan [1 ]
机构
[1] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea
[2] Sungkyunkwan Univ, Coll Pharm, Suwon 440746, South Korea
[3] Univ Utah, Dept Pharmaceut & Pharmaceut Chem, Ctr Controlled Chem Delivery, Salt Lake City, UT 84112 USA
[4] Hanyang Univ, Dept Bioengn, Seoul 133791, South Korea
关键词
vascular endothelial growth factor; siRNA delivery; anti-angiogenesis; polyelectrolyte complex micelles;
D O I
10.1016/j.jconrel.2008.03.008
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
For efficient cancer therapy, small interfering RNA (siRNA) should be stably and efficiently delivered into the target tissue and readily taken up by cancer cells. To address these needs, a polyelectrolyte complex (PEC) micelle-based siRNA delivery system was developed for anti-angiogenic gene therapy. The interaction between poly(ethylene glycol) (PEG)-conjugated vascular endothelial growth factor siRNA (VEGF siRNA-PEG) and polyethylenimine (PEI) led to the spontaneous formation of nanoscale polyelectrolyte complex micelles (VEGF siRNA-PEG/PEI PEC micelles), having a characteristic siRNA/PEI PEC inner core with a surrounding PEG shell layer. Intravenous as well as intraturnoral administration of the PEC micelles significantly inhibited VEGF expression at the tumor tissue and suppressed tumor growth in an animal tumor model without showing any detectable inflammatory responses in mice. Upon examination of the PEC micelle distribution and in vivo optical imaging following intravenously injection, enhanced accumulation of the PEC micelles was also observed in the tumor region. This study demonstrates the feasibility of using PEC micelles as a potential carrier for therapeutic siRNAs in local and systemic treatment of cancer. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:107 / 116
页数:10
相关论文
共 52 条
[1]   In vivo fate of phosphorothioate antisense oligodeoxynucleotides: Predominant uptake by scavenger receptors on endothelial liver cells [J].
Bijsterbosch, MK ;
Manoharan, M ;
Rump, ET ;
DeVrueh, RLA ;
vanVeghel, R ;
Tivel, KL ;
Biessen, EAL ;
Bennett, CF ;
Cook, PD ;
vanBerkel, TJC .
NUCLEIC ACIDS RESEARCH, 1997, 25 (16) :3290-3296
[2]   Biodistribution of phosphodiester and phosphorothioate siRNA [J].
Braasch, DA ;
Paroo, Z ;
Constantinescu, A ;
Ren, G ;
Öz, OK ;
Mason, RP ;
Corey, DR .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (05) :1139-1143
[3]   Increased hypoxia correlates with increased expression of the angiogenesis marker vascular endothelial growth factor in human prostate cancer [J].
Cvetkovic, D ;
Movsas, B ;
Dicker, AP ;
Hanlon, AL ;
Greenberg, RE ;
Chapman, JD ;
Hanks, GE ;
Tricoli, JV .
UROLOGY, 2001, 57 (04) :821-825
[4]   siRNAs: Applications in functional genomics and potential as therapeutics [J].
Dorsett, Y ;
Tuschl, T .
NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (04) :318-329
[5]   Killing the messenger: Short RNAs that silence gene expression [J].
Dykxhoorn, DM ;
Novina, CD ;
Sharp, PA .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2003, 4 (06) :457-467
[6]   Size comparison between proteins PEGylated with branched and linear Poly(Ethylene glycol) molecules [J].
Fee, Conan J. .
BIOTECHNOLOGY AND BIOENGINEERING, 2007, 98 (04) :725-731
[7]   RNA interference in cancer [J].
Gartel, AL ;
Kandel, ES .
BIOMOLECULAR ENGINEERING, 2006, 23 (01) :17-34
[8]   Post-transcriptional gene silencing by double-stranded RNA [J].
Hammond, SM ;
Caudy, AA ;
Hannon, GJ .
NATURE REVIEWS GENETICS, 2001, 2 (02) :110-119
[9]   An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells [J].
Hammond, SM ;
Bernstein, E ;
Beach, D ;
Hannon, GJ .
NATURE, 2000, 404 (6775) :293-296
[10]   RNA interference [J].
Hannon, GJ .
NATURE, 2002, 418 (6894) :244-251